2 completed, 1 terminated. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow epeleuton: new trials by email Literature Review of epeleuton trials Research Report on epeleuton
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pharmacokinetics, Pharmacodynamics and Safety of Epeleuton in Patients With Sickle Cell Disease Epeleuton - Sickle Cell Disease | Phase 2 | Completed | Afimmune | 35 | 2024-01-10 | 2026-05-04 |
| Assess Efficacy and Safety of Epeleuton in Patients With Hypertriglyceridemia and Type 2 Diabetes DS102, Placebo - Hypertriglyceridemia, Type 2 Diabetes | Phase 2 | Terminated | Afimmune | 233 | 2020-10-13 | 2023-06-12 |
| Safety And Efficacy Study Of Orally Administered Epeleuton In Patients With NAFLD Placebo capsules, Epeleuton - Non Alcoholic Fatty Liver Disease | Phase 2 | Completed | Afimmune | 96 | 2016-12-20 | 2022-10-12 |
Anemia, Sickle Cell (1) · Diabetes Mellitus, Type 2 (1) · Hypertriglyceridemia (1) · Non-alcoholic Fatty Liver Disease (1)
Afimmune (3)
Georgia (2) · United States (2) · Canada (1) · Germany (1) · Israel (1) · Latvia (1) · Switzerland (1) · Ukraine (1) · United Kingdom (1)
Markus Weissbach, MD (1) · Philip Newsome, MBChB, FRCPE, Ph.D (1)
2016 (1)